Utility package articles
Marketing and technical materials for QC, procurement and implementation teams. Search uses a shared RU/EN article index.
Materials
105RPH isotope and class index
Classifier for 279 radiopharmaceutical utilities: use-case classes, organs and systems, isotope families, workflow, and related API, instrumental and medical-device layers. Universal navigation across FUZKK radiopharmaceutical and related utilities: from a medical class and organ system to an isotope, workflow stage and a specific utility. The layers are not mutually exclusive: API describes calculation or rule-based logic; instrumental covers laboratory and imaging measurement outputs; medical devices covers equipment state, software lifecycle, safety and radiation-physics context.
Top radiopharmaceutical companies and FUZKK RPH / PetRad QC utilities
Portal article based on the Top Companies Radiopharmaceuticals image: 23 companies, radiopharmaceuticals/nuclear medicine areas and a map of applicable FUZKK RPH / PetRad QC scenarios.
Article: RPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
Article: Lumex QC Suite
A single Lumex package combining the former Lumex and Lumex2 sets: instrumental and general pharmaceutical QC, AAS/ICP, CE, HPLC, NIR/PAT, stability, dissolution, content uniformity, system suitability and statistical control.
Contraceptives QC Suite
Quality-control package for contraceptives: hormonal APIs, fixed combinations, implants, rings and intrauterine systems. The article is structured as a commercial and technical package card for QC, validation, integration and pilot discussion.
ROTOP Pharmaka: manufacturer profiles and specific FUZKK Utilities
Bilingual FUZKK Portal article: ROTOP Pharmaka as a radiopharma/CDMO manufacturer, product profiles, suitable FUZKK suites and specific utilities for pilot QC mapping.
Pharmaceutical laboratory equipment: simplified Lumex and LabEx map
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Liquid Biopsy Companies: simplified FUZKK map without Medical Devices
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Veterinary Vaccine Companies: simplified FUZKK map without Medical Devices
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Advanced Wound Care Companies: simplified FUZKK map without Medical Devices
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Article: PetRad3: expanded PET/SPECT and radiopharmaceutical QC package
A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.
Hematologic Malignancies: simplified map of existing FUZKK utilities
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Article: PetRad2: advanced radiopharmaceutical QC package
A curated set of new utilities for radionuclide control, targeted alpha therapy, specific activity, radiolysis stability and preliminary dosimetry calculations.
151 Radiopharma Developers: simplified FUZKK map without Medical Devices
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Skin Care Products Companies: simplified FUZKK map without Medical Devices
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
Article: Argentina: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Australia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Brazil: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Bangladesh: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: China: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Canada: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Democratic Republic of the Congo: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Colombia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Germany: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Algeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Egypt: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Ethiopia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: France: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Indonesia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: United Kingdom: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: India: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Iran: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Japan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Italy: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Kenya: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Mexico: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: South Korea: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Myanmar: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Nigeria: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Pakistan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Russia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Philippines: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Saudi Arabia: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Thailand: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Sudan: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Turkey: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Tanzania: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Uganda: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: United States: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: Vietnam: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Article: South Africa: national essential medicines QC package
QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.
Traditional Chinese Medicine QC Utility Map
QC utility package for TCM: botanical identity, fingerprint consistency, marker compounds, decoction pieces, Paozhi processing, pesticides, mycotoxins, heavy metals, sulfur fumigation, microbial limits and adulteration screening.
Addiction Medicine & Controlled Substances QC Suite: QC Utility Fit Map
Standard article for the Addiction Medicine & Controlled Substances QC Suite package: 39 existing FUZKK utilities grouped by QC workflows.
Biopharmaceuticals Core: QC Utility Fit Map
Focused article for the Biopharmaceuticals Core package: 60 utilities for HCP, mAbs/biosimilars, proteins/peptides, sterility and release-adjacent QC. Added RavulizumabQualityChecker for mAb / complement C5 inhibitor workflow.
Biopharmaceuticals Extended: FUZKK Utility Fit Map
Extended broad-coverage article: mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, viral safety, sterile release, microbiology, water, cleanroom and stability. Added RavulizumabQualityChecker for mAb / complement C5 inhibitor workflow.
Sinopharm: manufacturing segments, subsidiaries, equipment and FUZKK utilities
A group-level Sinopharm mapping covering CNBG, plasma products, Shyndec, China TCM, Taiji, medical equipment, engineering, logistics and R&D—from equipment and data to specific FUZKK utilities.
Instrumental:Medical Devices — from Lumex/LabEx to lifecycle utilities
For every Lumex/LabEx utility, the article maps Medical Devices utilities for QMS, risk, software, cybersecurity, calibration, sterile consumables and validated data flow.
Medical Devices:Instrumental — from lifecycle utility to Lumex/LabEx evidence
For every Medical Devices utility, the article maps Lumex/LabEx utilities that may provide direct laboratory evidence or representative validated-instrument context.
FUZKK Cross Mapping: API, instrumental and Medical Devices utilities
An overview of four cross-mapping articles and the Medical Devices catalog: a bidirectional map connecting product/API utilities, Lumex/LabEx, equipment, software and lifecycle evidence.
Veterinary Vaccine Companies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 92 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 8 companies using existing utilities only.
Skin Care Companies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 161 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 2 companies using existing utilities only.
Liquid Biopsy Companies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 109 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 9 companies using existing utilities only.
Hematologic Malignancies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 154 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 8 companies using existing utilities only.
Advanced Wound Care Companies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 116 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 0 companies using existing utilities only.
Radiopharma Companies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 78 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 17 companies using existing utilities only.
Radiofrequency Ablation Companies: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 71 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 0 companies using existing utilities only.
Pharma Lab Equipment Manufacturers: Product/API, Lumex, LabEx and Medical Devices Map with Portfolio Evidence
Full 2026 v2 version: 162 companies; three layers are shown for every company: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Separate “Possibly relevant based on the public portfolio” suggestions were added for 0 companies using existing utilities only.
Radiofrequency Ablation Devices: simplified FUZKK map without Medical Devices
Compact version. The full article shows three FUZKK layers: Product/API, Instrumental and Medical Devices; the Instrumental layer is split into separate Lumex and LabEx columns. Where public evidence is available, a separate “Possibly relevant” block contains product-specific utilities.
CAR-T and Cell Therapy: a 23-Company FUZKK Utility Map
23 companies from the supplied infographic, mapped to direct CAR-T checkers and Product/API, Lumex, LabEx and Medical Devices layers. The PNG is embedded in the body as Base64.
Hyperpolarized xenon: lifecycle QC from cylinder to image
A concise overview of hyperpolarized Xe-129, adjacent Xe-133/Xe-127 workflows and a new 29-utility suite covering gas, SEOP, MRI/SPECT, safety, transport, scavenging and recovery.